rts logo

Check out this: Heron Therapeutics Inc (HRTX) could be on the verge of a big rally

Heron Therapeutics Inc (NASDAQ: HRTX) is 117.06% higher on its value in year-to-date trading and has touched a low of $0.50 and a high of $3.90 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HRTX stock was last observed hovering at around $3.60 in the last trading session, with the day’s gains setting it 0.09%.

Currently trading at $3.69, the stock is 9.54% and 24.29% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.11 million and changing 2.50% at the moment leaves the stock 82.73% off its SMA200. HRTX registered 210.08% gain for a year compared to 6-month gain of 161.70%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 25.51% loss in the last 1 month and extending the period to 3 months gives it a 53.11%, and is -4.40% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.66% over the week and 6.33% over the month.

Heron Therapeutics Inc (HRTX) has around 126 employees, a market worth around $555.90M and $132.10M in sales. Fwd P/E is 377.30. Profit margin for the company is -61.28%. Distance from 52-week low is 638.00% and -5.38% from its 52-week high. The company has generated returns on investments over the last 12 months (-56.90%).

with sales reaching $35.89M over the same period.The EPS is expected to grow by 86.11% this year, but quarterly earnings will post 16.40% year-over-year. Quarterly sales are estimated to grow 13.00% in year-over-year returns.

Heron Therapeutics Inc (HRTX) Top Institutional Holders

The shares outstanding are 150.29M, and float is at 139.43M with Short Float at 21.71%.

Heron Therapeutics Inc (HRTX) Insider Activity

The most recent transaction is an insider purchase by Forbes William P,the company’sEVP, Chief Development Officer. SEC filings show that Forbes William P bought 25,000 shares of the company’s common stock on Nov 17 ’23 at a price of $1.09 per share for a total of $27250.0. Following the purchase, the insider now owns 79000.0 shares.

Heron Therapeutics Inc disclosed in a document filed with the SEC on Nov 16 ’23 that Collard Craig A (Chief Executive Officer) bought a total of 150,000 shares of the company’s common stock. The trade occurred on Nov 16 ’23 and was made at $0.92 per share for $0.14 million. Following the transaction, the insider now directly holds 0.19 million shares of the HRTX stock.

Still, SEC filings show that on Nov 16 ’23, Duarte Ira (EVP, Chief Financial Officer) acquired 85,000 shares at an average price of $0.89 for $75599.0. The insider now directly holds 85,000 shares of Heron Therapeutics Inc (HRTX).

Related Posts